共 169 条
[1]
Bashey A(2013)T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation J Clin Oncol 31 1310-1316
[2]
Zhang X(2010)High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation Immunol Res 47 65-77
[3]
Sizemore CA(2014)Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts Biol Blood Marrow Transplant 20 1573-1579
[4]
Manion K(2015)Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide Blood 125 3024-3031
[5]
Brown S(2015)Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia Blood 126 1033-1040
[6]
Holland HK(2014)Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS Blood 124 3817-3827
[7]
Morris LE(2014)Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation Blood 124 2596-2606
[8]
Solomon SR(2013)Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning Biol Blood Marrow Transplant 19 117-122
[9]
Luznik L(2015)Optimal threshold and time of absolute lymphocyte count assessment for outcome prediction after bone marrow transplantation Biol Blood Marrow Transplant 29 1069-1075
[10]
Fuchs EJ(2015)A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia Leukemia undefined undefined-undefined